PRLD
Prelude Therapeutics Inc
3.90$
-1.3%
vs. previous close
Closing price · As of: Sep 30, 2026
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | 100.0% | 100.0% | |
| – | – | – | – | – | – | 25.3% | 14.1% | |
| – | – | – | – | – | – | 100.0% | 85.9% | |
| – | – | – | – | – | – | 1,685.6% | 776.8% | |
| – | – | – | – | – | – | 410.3% | 184.6% | |
| – | – | – | – | – | – | 2,095.9% | 947.2% | |
| – | – | – | – | – | – | -1,995.9% | -861.3% | |
| – | – | – | – | – | – | -1,816.8% | -819.6% | |
| – | – | – | – | – | – | -1,816.8% | -819.6% | |
| – | – | – | – | – | – | -1,791.4% | -805.5% |
Data as of: September 30, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.